| Literature DB >> 36045409 |
Ricardo Cardoso1,2, Adérito Seixas3,4, Sandra Rodrigues3, Isabel Moreira-Silva3,5, Nuno Ventura3, Joana Azevedo3, Filippo Monsignori3.
Abstract
OBJECTIVE: To determine the effect of sustained natural apophyseal glide (SNAG) on Flexion Rotation Test, pain intensity, and functionality in subjects with Cervicogenic Headache (CH).Entities:
Keywords: Cervicogenic headache; Physiotherapy; Randomized controlled trials; SNAG; Sustained natural apophyseal glide
Year: 2022 PMID: 36045409 PMCID: PMC9434842 DOI: 10.1186/s40945-022-00144-3
Source DB: PubMed Journal: Arch Physiother ISSN: 2057-0082
Description of the components in PICO strategy for the systematic review
| Acronym | Definition | Description |
|---|---|---|
| P | Patient | individuals with Cervicogenic Headache |
| I | Intervention | Sustained Natural Apophyseal Glide |
| C | Comparison | control, placebo or other standard intervention |
| O | Outcome | Flexion Rotation Test, pain intensity and functionality |
Fig. 1PRISMA flow diagram of the literature selection process
Summary of included studies
| Authors (years) | Objective of the study | Sample size / therapist training / study design | Treatment Method / treatment period and evaluation | Outcome measures | Results |
|---|---|---|---|---|---|
| To investigate the efficacy of the treatment of C1-C2 self-SNAG and the effects on the change of FRT and symptoms related to cervicogenic headache | 13 M; 19 F MA: 36 years / Performed by 3 professionals/ RCT-Parallel | Trial Period: 12 months CG: False mobilization of C1-C2 using the cervical self-SNAG strap 2 times a day SG1: Self mobilization (self-SNAG) of C1-C2 using the cervical self-SNAG strap 2 times a day | FRT MMHI | CG: ↑ FRT ( SG1: ↑ FRT ( FRT: SG1 > CG MMHI: SG1 > CG | |
[ | To investigate the effect of the SNAG technique on the duration of headache in middle-aged women with CH | 37 F MA: 45 years / Performed by 3 professionals / RCT-Parallel | Trial Period: 7 weeks CG: Placebo mobilization of the neck area with pain—3 × week (20 min) for 4 weeks SG1: SNAG technique—3 × week (20 min) for 4 weeks | VAS NDI HD | CG: ↑ VAS ( SG1: ↑ VAS ( VAS: SG1 > CG NDI: CG = SG1 HD: SG1 > CG |
| To study the effects of the SNAG technique and strengthening muscles in the cervical spine in the relief of cervicogenic headache | M;F (Not specified) MA: 35 years/ Performed by 2 professionals/ RCT-Parallel | Trial Period: 1 week CG: TENS in the paraspinal region of the cervical spine combined with deep muscle strengthening for the cervical region SG1: C1-C2 SNAG 10 × 10 s, combined with deep muscle strengthening for the cervical region | VAS SDCM | GC: ↑ VAS( ( SG1: ↑ VAS( VAS: SG1 > CG SDCM: SG1 = CG | |
[ | Search for the effects of SNAG (Mulligan) and PA (Maitland) techniques on cervicogenic headache and compare them with a control group | 12 M; 11 F MA: 30 years/ (Not specified)/ RCT-Parallel | Trial Period: 1 week CG: n = 6 sessions (active neck exercises + strengthening and stretching exercises) SG1: n = 6 SNAG sessions (4 × 10 s.) SG2: n = 6 sliding sessions central PA, lateral PA (from 3 × 60 to 5 × 120 oscillations) | FRT HDI | CG: ↑ FRT ( SG1: ↑ FRT ( SG2: ↑ FRT ( FRT: CG = SG1 = SG2 HDI1: CG > SG2 |
[ | Evaluate the effectiveness of dry needling combined with SNAG C1-C2 in improving PPT and reducing disability due to cervicogenic headache | 37 M; 77F MA: 37 years/ Performed by 3 professionals/ RCT-Parallel | Trial Period: 6 weeks SG1: Dry Needling SG2: C1-C2 SNAG SG3: GE1 + GE2 | HDI PPT-1 PPT-2 PPT-3 | SG1: ↑ HDI ( SG2: ↑ HDI ( SG3: ↑ HDI ( HDI: SG3 > SG2 > SG1 PPT-1: SG3 > SG2 > SG1 PPT-2: SG3 > SG1 > SG2 PPT-3: SG3 > SG1 > SG2 |
[ | To compare the effects of the SNAG and MET techniques on the life management of subjects with cervicogenic headache | 6 M; 24 F MA: 26 years/ Performed by 4 professionals/ RCT-Parallel | Trial Period: 4 weeks SG1: SNAG 3 sets of 5 repetitions SG2:MET 6 sets de 5 repetitions | VAS HDI | SG1: ↑ VAS ( SG2: ↑ VAS ( VAS: SG2 > SG1 HDI2: SG2 > SG1 |
[ | To determine the effect of the SNAG technique on C1-C2 on cervicogenic headache and associated dizziness | 28 M; 20F MA: 29 years/ Performed by a therapist/ RCT-Parallel | Trial Period: 6 months SG1: SNAG C2 (10 × 10 s. / 30 s rest each repetition) SG2: C1-C2 SNAG Half-Rotation (10 × 10 s / 30 s of rest each repetition) SG3: Combination of GE1 + GE2 (5 repetitions of each technique) | NDI DHI FRT | SG1: ↑ FRT (p < 0.001); ↑ DHI ( SG2: ↑ FRT ( SG3: ↑ NDI ( ( NDI: SG3 > SG1 = SG2 FRT: SG3 > SG1 = SG2 DHI: SG1 > SG3 > SG2 |
| To investigate the effect of SNAGs in the treatment of cervicogenic headache | 0 M; 40 F MA: 22 years/ Performed by a manual therapist/ RCT-Parallel | Trial Period: 4 weeks SG1: 10 × 10 s; 3 × week (20 min; 12 sessions) CG: received placebo treatment (contact pressure of the hand touching the disturbed joint) 10 × 10 s; 3 × week (20 min; 12 sessions) | VAS (assessed on week 1, 2, 3 and 4) | SG1: ↑ VAS ( VAS: SG1 > CG on week 3 ( |
Code:↑—improvement; >—significantly better; DHI Dizziness Handicap Inventory, F Female, FRT Flexion-Rotation Test, HD Headache Duration, HDI Headache Disability Inventory, HDI Headache Disability Index, M Male, MET Muscular Energy Technique, MA Mean age, MMHI Marginal Means-Headache Index, NDI Neck Disability Index, PPT Pressure Point Threshold, PPT1 Pressure Point Threshold Over Suboccipital Area, PPT2 Pressure Point Threshold Over C5-C6 Paraspinal Area, PPT3 Pressure Point Threshold Over the Trapezius Muscle, SDCM Strength Deep Core Muscle, TENS Transcutaneous Electrical Nerve Stimulation, VAS Visual Analogic Scale
Fig. 2Methodological quality assessment of the included studies with PEDro scale. (2) Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received); (3) allocation was concealed; (4) the groups were similar at baseline regarding the most important prognostic indicators; (5) there was blinding of all subjects; (6) there was blinding of all therapists who administered the therapy; (7) there was blinding of all assessors who measured at least one key outcome; (8) measures of at least one key outcome were obtained from more than 85%; of the subjects initially allocated to groups; (9) all subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by “intention to treat”; (10) the results of between-group statistical comparisons are reported for at least one key outcome; (11) the study provides both point measures and measures of variability for at least one key outcome